Progyny, Inc. (PGNY)
| Market Cap | 4.25B |
| Revenue (ttm) | 385.97M |
| Net Income (ttm) | 57.57M |
| Shares Out | 88.53M |
| EPS (ttm) | -0.99 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 12 |
| Last Price | $47.86 |
| Previous Close | $48.76 |
| Change ($) | -0.90 |
| Change (%) | -1.85% |
| Day's Open | 47.89 |
| Day's Range | 47.42 - 48.74 |
| Day's Volume | 1,002,882 |
| 52-Week Range | 21.21 - 59.56 |
NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, toda...
Progyny (PGNY) delivered earnings and revenue surprises of 87.50% and 0.46%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Reports Record First Quarter Revenue of $122.1 Million, Reflecting 51% GrowthIssues Revenue Guidance of $126.0 to $131.0 Million for the Second Quarter of 2021, Reflecting Growth of 95% to 103%Continues...
NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wi...
NEW YORK, April 15, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, Apr...
When a company's return on equity ratio tops most of its competitors, it indicates the company has been very efficient in generating earnings.
Netflix and Facebook are among the top stocks for April. Q.ai's Artificial Intelligence has also dug up top tech stocks, top consumer stocks, top quality value stocks, and top growth stocks.
As the major indices drop with fears of rising bond yields, Q.ai's Artificial Intelligence has assessed each firm to bring you today's best short plays.
Amid real potential for another sell-off, the deep learning algorithms at Q.ai have crunched the data to give you top shorts for today.
All major indices are projected to end the week with losses, as the Dow Jones fell 70 points, the S&P 500 traded flat, and the Nasdaq mildly gained 0.2%. But Q.ai's deep learning algorithms can help y...
Progyny, a company that handles fertility benefits for other companies, managed to close out 2020 with more customers. Meanwhile, Progyny stock scored a respectable gain during the year.
Growth stocks opened the day with significant losses as the 10-year yield climbed to its highest level since last January. But Q.ai's deep learning algorithms have assessed the data to bring you today's...
Although the Dow Jones gained 40 points, the S&P 500 fell 0.4%, and the Nasdaq dropped 1.1%. Q.ai's deep learning algorithms are here to help you make the most of this market with today's best short plays.
Stocks have dropped again due to bond yields. In the meantime, Q.ai's Artificial Intelligence has assessed the data to bring you today's best short plays.
Fertility-benefits manager Progyny topped fourth-quarter estimates but gave cautious guidance late Wednesday. The post Progyny Beats As Fertility Clients Jump Amid Pandemic But Outlook Weak appeared fir...
Reports Record Fourth Quarter Revenue of $100.3 MillionIssues Revenue Guidance of $520.0 to $540.0 Million for 2021, Reflecting Growth of 51% to 57%
Why these two stocks are strong buys.
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...
Two innovative small companies with scorching growth and one bargain biotech.
NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wil...
This fertility stock could have serious long-term potential.
Nio, BlackBerry, Tilray, Five9 and Progyny were our top stock trades for Tuesday. Let's check out the charts after a long holiday weekend.
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...
NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...
Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2020 Results - Earnings Call Transcript
Progyny went public in October 2019, raising $130 million. The firm provides fertility and family planning benefit services in the United States.
Progyny (PGNY) delivered earnings and revenue surprises of 0.00% and 6.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Progyny (NASDAQ:PGNY) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 66.67% over the past year to $0.05, which were in li...
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wil...
Pharmacy benefits manager Progyny Inc (NASDAQ: PGNY) is trading 8.22% lower on thin volume in the pre-market session on Thursday. The company disclosed in SEC form 4 that TPG Group Holdings, who are mor...
Researchers Studied Journey Level Analysis of Progression to Treatment Versus Drop Out in a Large Cohort of Patients with Access to a Defined Fertility Benefit Researchers Studied Journey Level Analysis...
NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, ...
Progyny provides employers with fertility benefits to help their employees build families.
Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating Officer Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating Officer
Progyny, Inc's (PGNY) CEO David Schlanger on Q2 2020 Results - Earnings Call Transcript
Reports Second Quarter Revenue of $64.6 MillionPatient Return to Treatment Faster Than ExpectedIssues Revenue Guidance of $323.0 to $340.0 Million for Full Year 2020, Reflecting Growth of 41% to 48%Issu...
Progyny Is Delivering Even During Lockdown
NEW YORK, July 22, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, w...
Progyny: In Its Third Trimester And Poised For Healthy Growth
Q1 earnings beat, and Progyny is lining up to do it again in Q2.
Progyny, Inc. (PGNY) CEO David Schlanger on Q1 2020 Results - Earnings Call Transcript
Company Well-Positioned to Successfully Manage COVID-Related Impacts Reports 72% Increase in First Quarter Revenue to $81.0 MillionReports $12.1 Million in Quarterly Operating Cash Flow, Adding to its A...
Progyny reports earnings after the close today as fertility clinics postpone procedures due to the coronavirus pandemic. The post Progyny Reports Earnings Late As Coronavirus Delays Fertility Services a...
Nasdaq Partners with Progyny to Bring Comprehensive and Inclusive Fertility and Family Building Benefits to its US Employees Nasdaq Partners with Progyny to Bring Comprehensive and Inclusive Fertility a...
NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, ...
Progyny, Inc. (PGNY) CEO David Schlanger on Q4 2019 Results - Earnings Call Transcript
Progyny earnings for Q4 are due after the close as the fertility benefits manager begins its selling season. The post Progyny Earnings Are Due Late; Start Of Selling Season Will Clarify Competition appe...
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimburseme... [Read more...]
| Industry Health Information Services | IPO Date Oct 25, 2019 |
| Stock Exchange NASDAQ | Ticker Symbol PGNY |
Analyst Forecasts
According to 4 analysts, the average rating for Progyny stock is "Strong Buy." The 12-month stock price forecast is 59.50, which is an increase of 24.32% from the latest price.